GEN1046
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GEN1046, covering 2024-04-30 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: GEN1046 Safety Trial in Patients With Malignant Solid Tumors [Phase 1, Phase 2]